Goutam Banerjee, Kamal Shokeen, Nilanjan Chakraborty, Saumya Agarwal, Arindam Mitra, Sachin Kumar, Pratik Banerjee
Journal: Current opinion in pharmacology 2021;60():158-167
PMID: 34425392
Ebola virus disease targets and destroys immune cells, including macrophages and dendritic cells, leading to impairment of host response. After infection, a combination of strategies including alteration and evasion of immune response culminating in a strong inflammatory response can lead to multi-organ failure and death in most infected patients. This review discusses immune response dynamics, mainly focusing on how Ebola manipulates innate and adaptive immune responses and strategizes to thwart host immune responses. We also discuss the challenges and prospects of developing therapeutics and vaccines against Ebola.
Copyright © 2021 Elsevier Ltd. All rights reserved.
Medical:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.